Product Information
FONDAPARINUX 2.5 MG/0.5 ML SYR is a generic product labeled by Eugia US LLC, priced at $20.8396 per ML under NDC 55150023010. Its NADAC has been published 162 times since Mar 18, 2020.
Strength
2.5 mg/.5mL
Manufacturer
Eugia US LLCNDC
55150023010
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
FONDAPARINUX SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA206918On Market Since
12/26/2017
Pharmacological Classes
Price Statistics
The NADAC for FONDAPARINUX 2.5 MG/0.5 ML SYR has been published 162 times since Mar 18, 2020, and over the history we have for it it has declined 48.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $20.8396 per ML |
|---|---|
| All-time high | $40.3736 (Mar 10, 2021) |
| All-time low | $18.9706 (Apr 22, 2026) |
| 52-week high | $28.4394 |
| 52-week low | $18.9706 |
| Median price | $27.3476 |
| Average price | $30.0670 |
| Largest weekly change | -39.2% (May 22, 2024) |
| Weeks tracked | 162 |
| Tracking since | Mar 18, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the FONDAPARINUX SODIUM market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of FONDAPARINUX 2.5 MG/0.5 ML SYR?
The current National Average Drug Acquisition Cost (NADAC) for FONDAPARINUX 2.5 MG/0.5 ML SYR, manufactured by Eugia US LLC, is $20.8396 per ML (NDC 55150023010), effective Jun 24, 2026.
How has the price of FONDAPARINUX 2.5 MG/0.5 ML SYR changed over time?
Over the history we have for it, the NADAC for FONDAPARINUX 2.5 MG/0.5 ML SYR has declined 48.4%. It has been tracked across 162 weekly CMS publications since Mar 18, 2020.
What are the highest and lowest recorded NADAC prices for FONDAPARINUX 2.5 MG/0.5 ML SYR?
Since Mar 18, 2020, the NADAC for FONDAPARINUX 2.5 MG/0.5 ML SYR has ranged from a low of $18.9706 (Apr 22, 2026) to a high of $40.3736 (Mar 10, 2021), with a median of $27.3476 per ML.
Are there cheaper alternatives to FONDAPARINUX 2.5 MG/0.5 ML SYR?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of FONDAPARINUX 2.5 MG/0.5 ML SYR, so no direct lower-cost alternative is listed.
Who manufactures FONDAPARINUX 2.5 MG/0.5 ML SYR?
FONDAPARINUX 2.5 MG/0.5 ML SYR (NDC 55150023010) is labeled by Eugia US LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification